Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$360.20 USD

360.20
13,477,635

+6.48 (1.83%)

Updated Oct 3, 2025 04:00 PM ET

After-Market: $360.51 +0.31 (0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.81%
2Buy17.98%
3Hold9.90%
4Sell5.43%
5Strong Sell2.74%
S&P50011.32%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (228 out of 245)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Zacks Equity Research

Humana (HUM) Surpasses on Q2 Earnings, Raises EPS Guidance

by Zacks Equity Research

Humana's (HUM) Q2 earnings register growth on the back of Medicare Advantage enrollment and solid strategies. The company also lifts its EPS outlook.

    Zacks Equity Research

    Molina Healthcare (MOH) Tops Q2 Earnings, Updates '18 View

    by Zacks Equity Research

    Molina Healthcare's (MOH) Q2 gains from a decline in expense. The company also revises its full-year guidance.

      Zacks Equity Research

      WellCare Health (WCG) Beats on Q2 Earnings, Updates Guidance

      by Zacks Equity Research

      WellCare Health's (WCG) second-quarter 2018 rides high on solid segmental performances.

        Zacks Equity Research

        Top Ranked Growth Stocks to Buy for August 1st

        by Zacks Equity Research

        Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 1st:

          Zacks Equity Research

          Community Health (CYH) Incurs Lower Loss Than Expected in Q2

          by Zacks Equity Research

          Community Health's (CYH) Q2 results suffer loss from decline in admissions.

            Zacks Equity Research

            Universal Health (UHS) Q2 Earnings Beat Estimates, Up Y/Y

            by Zacks Equity Research

            Universal Health's (UHS) second-quarter earnings benefit from solid performances by the Acute Care and Behavioral Hospitals.

              Zacks Equity Research

              HCA Healthcare (HCA) Beats on Q2 Earnings, Revises Guidance

              by Zacks Equity Research

              HCA Healthcare's (HCA) second-quarter earnings grow on the back of solid revenues and increased admissions.

                Zacks Equity Research

                Anthem (ANTM) Q2 Earnings Beat, Membership Declines, View Up

                by Zacks Equity Research

                Anthem (ANTM) Q2 earnings gain on medical cost improvement, partly offset by membership declines.

                  Zacks Equity Research

                  Centene (CNC) Beats Q2 Earnings Estimates, Revises Guidance

                  by Zacks Equity Research

                  Centene's (CNC) second-quarter earnings beat on revenue and membership growth. The top line improves owing to Health Insurance Marketplace business, acquisitions and expansions.

                    Swarup Gupta headshot

                    Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress

                    by Swarup Gupta

                    The index posted impressive gains this week, boosted by a strong economy and expectations of robust earnings.

                      Tirthankar Chakraborty headshot

                      4 Big-Name Stocks to Buy on Blockbuster Q2 Earnings

                      by Tirthankar Chakraborty

                      We select four big names that have reported remarkable second-quarter results and are poised to scale north on solid fundamentals.

                        Nalak Das headshot

                        Dow Posts Longest Winning Run in Two Months: 4 Top Picks

                        by Nalak Das

                        A strong bunch of 15 stocks out of the portfolio of 30 in the Dow has provided positive returns year to date.

                          Sweta Killa headshot

                          Healthcare ETFs to Ride on UnitedHealth's Solid Q2 & Outlook

                          by Sweta Killa

                          Investors should tap the opportunity with ETFs having the largest allocation to UnitedHealth.

                            Zacks Equity Research

                            Company News For Jul 18, 2018

                            by Zacks Equity Research

                            Companies in the news are: UNH, CMA, WMT, MSFT, GS

                              Zacks Equity Research

                              Why Dip in UnitedHealth Stock Post Q2 is a Good Entry Point

                              by Zacks Equity Research

                              Despite concerns over some parts of UnitedHealth's (UNH) Q2 earnings, its long-term growth prospects are bright.

                                Zacks Equity Research

                                Watch Out For Goldman

                                by Zacks Equity Research

                                Watch Out For Goldman

                                  Mark Vickery headshot

                                  Goldman Beats in Blankfein's Final Quarter

                                  by Mark Vickery

                                  Goldman Sachs (GS) CEO and Chairman Lloyd Blankfein announced his replacement this morning as the company he's run for the past 12 years easily beat earnings and revenue projections in its Q2 report.

                                    Zacks Equity Research

                                    UnitedHealth's (UNH) Q2 Earnings Beat, 2018 Guidance Up

                                    by Zacks Equity Research

                                    UnitedHealth (UNH) Q2 earnings beat on membership growth, 2018 guidance pulled up.

                                      Zacks Equity Research

                                      UnitedHealth (UNH) Q2 Earnings Beat on Revenue Growth

                                      by Zacks Equity Research

                                      UnitedHealth's (UNH) Q2 earnings gained on revenue and membership growth.

                                        Ryan McQueeney headshot

                                        UnitedHealth (UNH) Loses 0.7% Ahead of Earnings: What To Watch

                                        by Ryan McQueeney

                                        Shares of UnitedHealth (UNH) lost about 0.7% during regular hours Monday, the last day of trading before it releases its latest quarterly earnings report. Here's what to expect on Tuesday morning.

                                          Tracey Ryniec headshot

                                          The 5 Most Spectacular Earnings Charts This Week

                                          by Tracey Ryniec

                                          These stocks are among the hottest on the Street. Can they keep their upward momentum?

                                            Zacks Equity Research

                                            How Will Membership Affect UnitedHealth's (UNH) Q2 Earnings?

                                            by Zacks Equity Research

                                            UnitedHealth (UNH) should see an increase in Public Group and International business, partially offset by lower commercial membership.

                                              Zacks Equity Research

                                              Will Higher Revenues Aid UnitedHealth's (UNH) Q2 Earnings?

                                              by Zacks Equity Research

                                              Continued strong performance across the company to aid UnitedHealth's (UNH) results.

                                                Zacks Equity Research

                                                JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings?

                                                by Zacks Equity Research

                                                With Johnson & Johnson (JNJ) and Novartis AG (NVS) scheduled to report on Jul 17 and Jul 18, respectively, this may be a good time to figure out which of these is a better stock.

                                                  Tracey Ryniec headshot

                                                  Trade Wars and Recessions: What Should Investors Do?

                                                  by Tracey Ryniec

                                                  The best thing investors can do is have a plan. Find out where you should be investing in this uncertain market.